Atlas Trials

Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X

Clinical trial NCT01869933 · COMPLETED

Trial details

NCT number
NCT01869933
Sponsor
OcuCure Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy (PDR)
Start date
2013-04-01
Primary completion
2013-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.